
Elvina Almuradova/LinkedIn
Apr 7, 2025, 16:54
Elvina Almuradova: It’s Not Just About Better Drugs – Tumor Biology Matters
Elvina Almuradova, Ambassador at European School of Oncology, shared on X about a recent paper by A. Papakonstantinou et al. published in ESMO Annals of Oncology:
“In HER2+ BC, ADCs are promising, but it’s not just about better drugs – tumor biology matters. As T-DXd rises, we must still protect early-stage patients from ILD. Time to focus on personalization.”
Authors: A. Papakonstantinou and T. Foukakis
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 10, 2025, 17:20
Apr 10, 2025, 17:01
Apr 10, 2025, 16:55